Company News for Jun 14, 2021

Zacks Equity Research Published on June 14, 2021

Shares of Vertex Pharmaceuticals Inc. (VRTX - Free Report) fell nearly 11% after the company stated that it is going to stop developing an experimental drug after it was found unlikely to be effective against AAT Deficiency disease.
Royal Caribbean Group’s (RCL - Free Report) shares fell 0.6% after the company stated that two passengers aboard its Celebrity Millennium Cruise ship had tested positive for COVID-19.
American Airlines Group Inc.’s (AAL - Free Report) shares rose 0.3% after the company said that it is going to invest $25 million into Vertical Aerospace, a flying taxi startup company.
Protagonist Therapeutics, Inc.’s (PTGX - Free Report) shares rose 17.1% after the company announced updated results from its ongoing Phase 2 study of rusfertide for polycythemia vera, which is a type of blood cancer, at the European Hematology Association 2021 Virtual Congress session.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.